These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8643882)

  • 1. Global tests for combination drug studies in factorial trials.
    Hung HM
    Stat Med; 1996 Feb; 15(3):233-47. PubMed ID: 8643882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a combination drug with multiple doses in unbalanced factorial design clinical trials.
    Hung HM
    Stat Med; 2000 Aug; 19(16):2079-87. PubMed ID: 10931512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large sample tests for binary outcomes in fixed-dose combination drug studies.
    Wang SJ; Hung HM
    Biometrics; 1997 Jun; 53(2):498-503. PubMed ID: 9192448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing for the existence of a desirable dose combination.
    Hung HM; Chi GY; Lipicky RJ
    Biometrics; 1993 Mar; 49(1):85-94. PubMed ID: 8513112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fixed-dose combinations in antihypertensive treatment: is it necessary to examine the effectiveness of each component?].
    Dechend R; Derer W; Müller DN
    MMW Fortschr Med; 2009 Nov; 151(45):46-7. PubMed ID: 19960726
    [No Abstract]   [Full Text] [Related]  

  • 6. Large sample tests for simultaneous comparison to multiple controls in terms of binomial proportions.
    Soulakova JN; Luo L
    J Biopharm Stat; 2013 May; 23(3):589-603. PubMed ID: 23611197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
    Papademetriou V; Hainer JW; Sugg J; Munzer D;
    Am J Hypertens; 2006 Dec; 19(12):1217-25. PubMed ID: 17161766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fallback tests in dose-response clinical trials.
    Dmitrienko A; Wiens B; Westfall P
    J Biopharm Stat; 2006; 16(5):745-55. PubMed ID: 17037269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes from treatment. Clinical applications from recent trials.
    Howes LG
    Aust Fam Physician; 1999 Jul; 28(7):707-10. PubMed ID: 10431429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for analyzing multilevel cluster-randomized studies with binary outcomes collected at varying intervals of time.
    Olsen MK; DeLong ER; Oddone EZ; Bosworth HB
    Stat Med; 2008 Dec; 27(29):6055-71. PubMed ID: 18825655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration.
    J Hypertens; 1998 Feb; 16(2):127-37. PubMed ID: 9535138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
    Leenen FH
    Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertension.
    Jamerson KA; Bakris GL; Wun CC; Dahlöf B; Lefkowitz M; Manfreda S; Pitt B; Velazquez EJ; Weber MA
    Am J Hypertens; 2004 Sep; 17(9):793-801. PubMed ID: 15363822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The analysis of a multiple-dose, combination-drug clinical trial using response surface methodology.
    Phillips JA; Cairns V; Koch GG
    J Biopharm Stat; 1992; 2(1):49-67. PubMed ID: 1300205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of several testing strategies for combination drug efficacy trials based on the closure principle.
    Soulakova JN
    Stat Med; 2009 Jan; 28(2):260-73. PubMed ID: 18991315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resampling in multiple-dose factorial designs.
    Frommolt P; Hellmich M
    Biom J; 2009 Dec; 51(6):915-31. PubMed ID: 20029896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed data.
    Vickers AJ
    BMC Med Res Methodol; 2005 Nov; 5():35. PubMed ID: 16269081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permutation test following covariate-adaptive randomization in randomized controlled trials.
    Hasegawa T; Tango T
    J Biopharm Stat; 2009; 19(1):106-19. PubMed ID: 19127470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Order-restricted tests for stratified comparisons of binomial proportions.
    Agresti A; Coull BA
    Biometrics; 1996 Sep; 52(3):1103-11. PubMed ID: 8805770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Average bioequivalence for two-sequence two-period crossover design with incomplete data.
    Lee JY; Kim BC; Park SG
    J Biopharm Stat; 2005; 15(5):857-67. PubMed ID: 16078389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.